Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit
Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit
Click here to reserve your seat Fireside Chat Scheduled for 2:00 PM ET on October 15, 2024
2024年10月15日美東時間下午2點舉行的爐邊聊天
BROOMFIELD, Colo., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Aclarion, Inc., ("Aclarion" or the "Company") (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today that Aclarion's CEO, Brent Ness, has been invited to present at the 2024 Maxim Healthcare Virtual Summit, presented by Maxim Group LLC, on Tuesday, October 15 th , 2024, at 2:00 p.m. E.T.
科羅拉多州布魯姆菲爾德，2024年10月10日（環球新聞社） - 健康科技公司Aclarion, Inc。（"Aclarion" 或 "公司"）（納斯達克股票代碼: ACON, ACONW），利用生物標誌物和專有的增強智能（AI）算法幫助醫生識別慢性腰痛的位置的健康科技公司Aclarion今天宣佈，Aclarion首席執行官布倫特·尼斯已受邀在2024年由Maxim Group LLC主辦的Maxim Healthcare虛擬峯會上演講，演講時間爲2024年10月15日星期二下午2點美東時間
Maxim senior analysts will host a wide range of biotechnology, diagnostic, medical device, and healthcare information technology companies in a series of presentations and interactive discussions with CEOs and key management.
Maxim資深分析師將邀請各種生物技術、診斷、醫療器械和醫療信息技術公司進行一系列演講和與首席執行官及關鍵管理人員的互動討論
Click here to reserve your seat
點擊這裏預留您的座位
About Aclarion, Inc.
關於Aclarion, Inc.
Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy ("MRS"), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies. For more information, please visit .
Aclarion是一家利用磁共振波譜學（"MRS"）、專有信號處理技術、生物標誌物和增強智能算法來優化臨床治療的健康科技公司。該公司首次通過Nociscan進入慢性腰痛市場，這是第一個經證據支持的saas-雲計算平台，用於非侵入性地幫助醫生區分腰椎間盤的疼痛與非疼痛。通過雲連接，Nociscan接收每個腰椎盤的磁共振波譜學（MRS）數據。在雲端，專有的信號處理技術提取和量化與盤痛有關的化學生物標誌物。生物標誌物數據被輸入專有算法以指示盤可能是疼痛源。當與其他診斷工具一起使用時，Nociscan提供對患者腰痛位置的關鍵洞察，使醫生能夠優化治療策略。欲了解更多信息，請訪問
Investor Contacts:
Kirin M. Smith
PCG Advisory, Inc.
646.823.8656
ksmith@pcgadvisory.com
投資者聯繫人：查看更多信息前往：
Kirin m. Smith
PCG Advisory, Inc.
646.823.8656
ksmith@pcgadvisory.com
Media Contacts:
Jodi Lamberti
SPRIG Consulting
612.812.7477
jodi@sprigconsulting.com
媒體聯繫人：
Jodi Lamberti
SPRIG諮詢公司
612.812.7477
jodi@sprigconsulting.com
譯文內容由第三人軟體翻譯。
